Eli Lilly's Growth Rate Is Fantastic, but This Number Is Even Better

Eli Lilly's valuation may seem high right now, but with fast earnings growth, today's price could look like a deal in a few years.Eli Lilly (LLY 0.21%) is a growth machine, with its business taking off due to its wildly successful diabetes drug Mounjaro, which recently was approved for weight-loss treatment under the name Zepbound. It could end up being the company's top seller in the near future. There is no shortage of reasons to be bullish on the company.Its sales have been rising at a rapid rate. But as ...